Tag: endometrial carcinoma

FDA Approves New Immunotherapy for Endometrial Cancer

The US Food and Drug Administration today gave an accelerated approval to the immunotherapy dostarlimab (Jemperli) for the treatment of recurrent or advanced endometrial cancer...

FDA Finalizes Guidance for Power Morcellators

Power morcellators can be safely used for some gynecologic surgeries, according to recent guidance from the US Food and Drug Administration (FDA), but doing so...

Cancer Rates on the Rise in Adolescents and Young Adults

Rates of cancer increased by 30% from 1973 to 2015 in adolescents and young adults (AYAs) (persons aged 15–39 years) in the United States, according...

Two-Drug Combo Standard of Care in Advanced Endometrial Cancer

Carboplatin plus paclitaxel (TC) should be the global first-line standard treatment for advanced endometrial cancer, new findings suggest. The combination proved to be noninferior to...

Medicare Will Test Pay Models for Radiation Oncology, Dialysis

Beginning in 2021, Medicare will test alternative methods of paying for radiation oncology and dialysis, with the giant federal insurer saying it is seeking to...

Promising Efficacy With Adavosertib in Uterine Serous Carcinoma

The experimental agent adavosertib showed hints of efficacy against recurrent uterine serous carcinoma in early data from a phase 2 trial. The overall response rate...